BMC Pulmonary Medicine
Scope & Guideline
Empowering innovation in pulmonary medicine for a healthier tomorrow.
Introduction
Aims and Scopes
- Pulmonary Disease Research:
The journal covers a wide range of pulmonary diseases, including chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, lung cancer, and pulmonary hypertension, emphasizing both clinical and translational research. - Innovative Diagnostic Techniques:
Research focusing on novel diagnostic approaches such as imaging techniques (e.g., CT and MRI), biomarkers, and endobronchial ultrasound is prevalent, promoting advancements in early detection and monitoring of lung diseases. - Therapeutic Interventions:
The journal publishes studies on various treatment modalities including pharmacological interventions, surgical approaches, and emerging therapies such as biologics and immunotherapy, aiming to improve patient outcomes. - Public Health and Epidemiology:
There is a strong emphasis on epidemiological studies that investigate the prevalence, risk factors, and socio-economic impacts of respiratory diseases, particularly in diverse populations. - Patient-Centered Outcomes:
Research evaluating health-related quality of life, patient experiences, and adherence to treatment regimens is prioritized, reflecting a commitment to improving patient care in pulmonary medicine. - Mechanistic and Pathophysiological Studies:
The journal includes studies that explore the underlying mechanisms of pulmonary diseases, including genetic, molecular, and cellular factors contributing to disease progression.
Trending and Emerging
- Telemedicine and Remote Monitoring:
The COVID-19 pandemic has accelerated the adoption of telehealth strategies in pulmonary care, with increasing research on the effectiveness of remote monitoring and virtual rehabilitation programs for managing chronic respiratory diseases. - Personalized Medicine and Biomarkers:
There is a growing focus on personalized approaches in treatment, including the use of biomarkers for tailoring therapies in conditions like asthma and idiopathic pulmonary fibrosis, reflecting advancements in precision medicine. - Impact of Environmental Factors:
Research increasingly addresses the effects of air pollution, occupational exposures, and climate change on respiratory health, emphasizing the need for public health interventions and policy changes. - Machine Learning and Artificial Intelligence:
The integration of machine learning and AI in diagnostic and prognostic models for lung diseases is emerging as a key area of research, enhancing predictive accuracy and patient outcomes. - Multimorbidity in Pulmonary Diseases:
An increasing number of studies are addressing the intersection of pulmonary diseases with other chronic conditions, focusing on comprehensive management strategies that consider the whole patient. - Health Disparities and Access to Care:
Research investigating health disparities in respiratory diseases, particularly among underserved populations, is gaining attention, highlighting the need for equitable healthcare access.
Declining or Waning
- Traditional Smoking Cessation Studies:
Research solely focused on methods for smoking cessation has declined, as the journal shifts toward integrated approaches that consider smoking as part of a broader spectrum of pulmonary disease management. - Single-Disease Focus:
There is a noticeable reduction in studies exclusively targeting individual diseases without considering comorbidities, as the journal increasingly emphasizes the interconnectedness of various respiratory conditions. - Basic Science without Clinical Relevance:
The journal appears to be moving away from purely basic science studies that do not have direct clinical implications, prioritizing translational research that impacts patient care. - Outdated Therapeutic Approaches:
Research centered on older therapeutic modalities without new insights or comparative effectiveness has diminished, reflecting a trend towards innovative and evidence-based treatment strategies.
Similar Journals
Turkish Thoracic Journal
Transforming the landscape of pulmonary medicine, one study at a time.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Transforming critical care practices with peer-reviewed excellence.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
RESPIROLOGY
Championing Collaborative Research in RespirologyRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
RESPIRATION
Elevating Knowledge in Respiratory HealthRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
Lung India
Advancing respiratory health through accessible research.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
Journal of Thoracic Disease
Elevating knowledge in the field of thoracic disease.Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.
Respiratory Investigation
Unlocking the future of respiratory health.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
BMJ Open Respiratory Research
Connecting researchers and practitioners for impactful respiratory solutions.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Annals of Thoracic Medicine
Advancing knowledge in thoracic health.Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Exploring innovative solutions for better patient outcomes.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.